OBESITY AS A RISK FACTOR FOR HEPATOBILIARY SYSTEM DAMAGE IN CHILDREN
Main Article Content
Abstract
This review provides facts about liver changes in obesity as part of non-alcoholic fatty liver disease. The review contains the pathogenesis and morphological characteristics of the development of this condition, the features of the clinical picture, as well as methods of invasive and non-invasive diagnostics.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
Guseva A.A. "Clinical and metabolic features of the state of the hepatobiliary system in children with overweight and obesity" ABSTRACT of the dissertation for the degree of candidate of medical sciences. Moscow 2015
Dedov I.I. et al., 2007; Kartelishev A.V., Rumyantsev A.G., 2010; Horse I.Ya. et al., 2011; Cattaneo A. I. et al., 2010
State of the hepatobiliary system and clinical and metabolic features in children with overweight and obesity / A.A. Guseva, M.M. Gurova, S.P. Guseva, I.V. Zorya // Actual problems of pediatric science and practice: materials of All Russia. conf. with international participation, dedicated 75th anniversary of Kursk. state honey. un-ta and the 10th anniversary of the creation of a pediatrician. fak. - Kursk, 2010. - S. 65-69
Garifulina L. M., Kholmuradova Z. E. INTEGRATED CLINICAL AND METABOLIC EVALUATION OF THE CONDITION OF CHILDREN WITH OBESITY AND ARTERIAL HYPERTENSION //Достижения науки и образования. – 2020. – С. 79.
R.M. Akhmedova, L.V. Sofronova, 2013; H.M. Snoek, T.Van Strien, J.M. Janssens, 2007, 2008; J.R. Silva et al., 2013
T. Van Strien, P. Osterveld, 2008; T. Ledoux et al., 2011; J.R. Silva, G. Capurro, M.P. Saumann, 2013
N.N. Minyailova, 2012; R.M. Akhmedova, L.V. Sofronova, 2013; C. Braet et al., 2008; R.M. Baños et al., 2011; J.R. Silva, G. Capurro, M.P. Saumann, 2013
Garifulina, . L. ., & Holmuradova, Z. (2022). CARDIOVASCULAR SYSTEM IN CHILDREN AND ADOLESCENTS WITH OBESITY. Journal of Hepato-Gastroenterological Research, 1(3), 24–27. https://doi.org/10.26739.2181-1008-2020-3-6
Roitberg G.E., 2007; Babayan M. L., Khavkin A. I., 2013; Bokova T.A., 2014; Ng M, Fleming T. et al., 2013; Nobili V, Alisi A, Newton KP, Schwimmer JB., 2016
"Non-alcoholic fatty liver disease in children according to ultrasound diagnostics" G.M. Dvoryakovskaya1, E.N. Kutyreva2, I.V. Dvoryakovsky1, T.V. Strokova2, S.A. Ivleva1, B.S. Kaganov. Journal "Gastroetorology" №4, 2012 pp. 53-62.
V. A. Peterkova and O. V. Remizov, 2004; Pavlov Ch.S. et al., 2010; Lazebnik L.B. et al., 2015; Koshurnikova A. S., Lukina E. V., 2017; Vernon G et al., 2011
Romasenko L.V., Turko T.V., 2007, Aleshina E.I. et al., 2014; Gurova M.M. et al., 2014
Bürgi AC, Dufour JF. Treatment of nonalcoholic steatohepatitis // Rev Prat. - 2012 Dec. - 62(10). – P.1425-1427
Zeng MD, Fan JG, Lu LG, Li YM, Chen CW, Wang BY, Mao YM. Guidelines for the diagnosis and treatment of nonalcoholic fatty liver diseases // J Dig Dis., 2008 May. - 9(2). – P.108-12.
Schwimmer J. B., Middleton M. S., Deutsch R. et al. A phase 2 clinical trial of metformin as a treatment for non-diabetic paediatric non-alcoholic steatohepatitis // Aliment. Pharmacol. Ther. — 2005. — Vol. 21. — P. 871–879.
Lavine J. E. Vitamin E treatment of nonalcoholic steatohepatitis in children: a pilot study // J. Pediatr. — 2000. — Vol. 136. — P. 734–738
Vajro P., Franzese A., Valerio G.60. et al. Lack of efficacy of ursodeoxycholic acid for the treatment of liver abnormalities in obese children // J. Pediatr. — 2000. — Vol. 136. — P. 739-743
"The state of the hepatobiliary system in children with obesity and metabolic syndrome" T. Bokova, Candidate of Medical Sciences, N. Ursova, Doctor of Medical Sciences, Professor, MONIKI. M.F. Vladimirsky, Moscow E-mail: bta2304@mail.ru. Journal "Gastroetorology" №1, 2011. pp.59-62
“The state of the liver and biliary tract in obesity in adolescents” Kalashnikova V.A. LOGBUZ "Children's Clinical Hospital", St. Petersburg, Russia 218-229pp.
"Modern advances in the evaluation of hepatic steatosis". Didenko V.I. State Institution "Institute of Gastroenterology of the National Academy of Medical Sciences of Ukraine", Dnepropetrovsk Journal "Gastroenterology" No. 3 (57) 2015 p.94-100
"Treatment of non-alcoholic fatty liver disease" O.B. Dzhambekova, G.R. Soroka, T.A. Panina. Bulletin of KazNMU, No. 3 (2) - 2013. P. 42-45
Non-invasive diagnosis of non-alcoholic fatty liver disease in obese children Kalashnikova V.A.1, Novikova V.P.2, Smirnova N.N. Experimental and clinical gastroenterology | issue 168 | No. 8 2019. P. 90-94
Stepanov Yu.M. Dyslipidemia in patients with non-alcoholic hepatic steatosis and biliary pathology and ways of its correction / Yu.M. Stepanov, A.Yu. Filippova // Contemporary gastroenterology. - 2010. - No. 4. - S. 46-51.
Stepanov Yu.M. Modern approaches to the verification of liver fibrosis / Yu.M. Stepanov, V.I. Didenko // Health of Ukraine. - 2013. - No. 18 (319). - S. 16-17.
Modern view on the pathogenesis, diagnosis and treatment of non-alcoholic fatty liver disease / S.N. Mekhtiev, E.N. Zinovieva, O.A. Mekhtieva, S.V. Sokolovsky // Preventive and Clinical Medicine. - 2010. - No. 3–4. — pp. 113-116.
Angulo P. Non-alcoholic fatty liver disease / Р. Angulo, K.D. Lindor // J. Gastroenterol. Hepatol. — 2002. — Vol. 17 ( Suppl. 1). — P. 186-190.
Kuntz E. Hepatology. Principles and Practice / E. Kuntz, H-D. Kuntz. — Heidelberg: Springer Medizin Verlag, 2006.
Pimanov S.I. American guidelines for the diagnosis and treatment of non-alcoholic fatty liver disease: something is being clarified / S.I. Pimanov // Gastroenterology. Supplement to Consilium Medicum. - 2012. - No. 2. - S. 92-96.
Bueverov A.O., Bogomolov P.O. Non-alcoholic fatty liver disease: substantiation of pathogenetic therapy // Clinical perspectives of gastroenterology, hepatology. - 2009. - No. 1. - S. 3-9.
Zvenigorodskaya L.A., Cherkashova E.A., Samsonova N.G. The use of hepatoprotectors in the treatment of non-alcoholic fatty liver disease // Farmateka. - 2011. - No. 15. - S. 58-63.
Guseinova Z.K., Uaizhanova D.Zh., Mandybaeva M.K., Peurichko A.V., Nurzhanova F.A., Zholbekova S.O. Evaluation of the effectiveness of Hepa-Merza in the treatment of patients with chronic diffuse liver diseases // International Journal on Immunorehabilitation (International Journal of Immunorehabilitation). - 2010. - U. 12. - No. 2. - S. 160-161.
Burkov S.G., Godunova S.A., Gurova N.Ya., Egorova N.V., Kulakova N.I., Leonova V.I., Podoprigora N.V., Grigorieva E.V. Modern possibilities of diagnostics and treatment of non-alcoholic fatty liver disease in polyclinic practice // Kremlin medicine. Clinical Bulletin. - 2012. - No. 1. - S. 131-135
Pavlov Ch.S. The place of puncture biopsy in the diagnosis of chronic diffuse liver diseases / Ch.S. Pavlov, D.V. Glushenkov, V.T. Ivashkin // Farmateka. - 2012. - No. S1. - p. 3.
Comparative characteristics of ultrasound and histological data in determining the degree of liver steatosis in patients with chronic viral hepatitis C / O.O. Golik, D.Yu. Konstantinov, L.L. Popova [et al.] // Ural Medical Journal. - 2010. - No. 7. - S. 69-72.
Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management / S. McPherson, T. Hardy, E. Henderson [et al.] // J. Hepatol. — 2015. — № 62 (5). — P. 1148-1155.
Hepatic steatosis estimated microscopically versus digital image analysis / A.R. Hall, A.P. Dhillon, A.C. Green [et al] // Liver Int. — 2013. — № 33 (6). — P. 926-935.
A new index for non-invasive assessment of liver fibrosis / N. Ichino, K. Osakabe, T. Nishikawa [et al] // World J. Gastroenterol. — 2012. — № 16. — P. 4809-4816.
Pat. No. 2403576 RUS. A method for diagnosing liver steatosis by biochemical markers / T. Poinar; publ. 02/03/2006.
Bellentani S. Prevalence of and risk factors for hepatic steatosis in Northern Italy / S. Bellentani et. al. // Ann. Intern. Med. — 2000. — № 132 (2). — Р. 112-117. http://www.springerlink.com / content / h32g2016tlwl8412 / fulltext.pdf.
Pimanov S.I. Alcoholic liver disease: new in American and European approaches / S.I. Pimanov, E.V. Makarenko, L.V. Tikhonov // Gastroenterology. Supplement to Consilium Medicum. - 2013. - No. 1. - S. 56-60.
Maccalau A.J. New information for non-alcoholic fatty liver disease / A.J. Maccalau // J. Clin. Gastroenterology. — 2002. — № 34. — P. 255-262.
Stepanov Yu.M. Clinical features of the course of non-alcoholic steatohepatitis depending on concomitant diseases / Yu.M. Stepanov, A.Yu. Filippova // Contemporary gastroenterology. - 2006. - T. 29, No. 3. - S. 4-7.
Minushkin O.N. Does the lengthening of the terms of treatment with Essentiale N lead to an increase in the effectiveness of therapy in patients with alcoholic liver damage? / HE. Minushkin, L.V. Maslovsky // Difficult patient. - 2004. - No. 3. - S. 18-22.
Hashimono E. Diagnostic criteria for non-alcoholic steatohepatitis / E. Hashimono // Nippon Rinsho. — 2006. — Vol. 64 (6). — P. 1025-1032.
Ternovoy S.K. Diagnostic value of hydrogen proton magnetic resonance spectroscopy of the liver in assessing the treatment of steatosis and steatohepatitis / S.K. Ternovoy, D.T. Abdurakhmanov, G.A. Shiryaev // Cardiological Bulletin. - 2014. - V. 9, No. 3. - S. 105-110.
Bueverova E.L. Atherogenic dyslipidemia and liver / E.L. Bueverova, O.M. Drapkina, V.T. Ivashkin // Ros. honey. lead. - 2008. - No. 1. - S. 17-23.
Morphofunctional changes in the organs of the hepatopancreatobiliary system in experimental dyslipidemia / A.D. Dibirov, V.A. Petukhov, D.A. Sleep [and others] // Bull. expert biol. and honey. - 2000. - No. 130 (7). - 45-50.
Clinical and morphological changes in the liver in atherogenic dyslipidemia and in the treatment of statins / L.B. Lazebnik, L.A. Zelenogorodskaya, I.A. Morozov [et al.] // Ter. archive. - 2003. - No. 5. - S. 8-12.